Kyle A Perry, MD

Kyle A Perry, MD

Physician

Specialty:General Surgery

Gender: Male

Academic Title: Professor in the College of Medicine

Research Program: Translational Therapeutics

  • About Me

    I am a surgeon who specializes in the surgical and endoscopic treatment of general surgical conditions. This includes treating gastroesophageal reflux, achalsia and esophageal cancer. My expertise in minimally invasive surgery provides my patients with many treatment options. I believe in providing patient-focused care. Listening and communicating clearly with my patients is very important to me. I strive to provide them with the most effective, least invasive treatment possible. This can help increase their comfort level and reduce recovery time from surgery. As a member of the Translational Therapeutics Program at the OSUCCC – James, my research focuses on prevention, surgical treatment and outcome improvement of esophageal, gastric and pancreatic cancers. In particular, I work on in vivo studies to improve surgical techniques and patient outcomes. I also study cancer prevention through the treatment of Barrett esophagus. One of my recent studies indicates that intramucosal cancer can be managed endoscopically, eliminating the need for esophagectomies in a significant number of patients. I have co-authored numerous articles in well-known publications, including Surgical Endoscopy and Minerva Chirurgica. I enjoy working in Ohio State's innovative and collaborative environment as we strive to create a cancer-free world. We take a comprehensive and well-coordinated team approach to patient care. This fosters excellence at every level and the highest standards of surgical care.

  • Clinical Expertise

    • Stomach Cancers
    • Hernia, Ventral
    • Barrett's Esophagus
    • Heartburn
    • Lipoma
    • Esophageal Motility Disorders
    • Gastroscopy
    • General Surgery
    • Gastrointestinal Cancers
    • Hernia, Abdominal
    • Esophageal Diseases
    • Hernia, Hiatal
    • Gastroesophageal Reflux
    • Hernia, Diaphragmatic
    • Esophageal Achalasia
    • Minimally Invasive Surgical Procedures
    • Hernia, Umbilical
    • Robotics
    • Esophageal Cancers
  • Research Interests

    • Gastroesophageal Reflux
    • Carcinoma
    • Neoplasms
    • Inflammation
    • Esophageal Achalasia
    • Deglutition Disorders
    • Pheochromocytoma
    • Esophageal Neoplasms
  • Where I See Patients

    Ohio State Martha Morehouse Outpatient Care

    Ohio State Martha Morehouse Outpatient Care

    Location Information
  • Education & Training

    Fellowship - Minimally Invasive Surgery

    • Oregon Health & Science University-OHSU
      Medical Staff Office, Portland, OR

    Internship - Surgery (General Surgery)

    • Rush University Medical Center
      1620 W Harrison St, Chicago, IL

    Residency - Surgery (General Surgery)

    • Rush University Medical Center
      1620 W Harrison St, Chicago, IL

    Medical School

    • Temple University School Of Medicine
      3400 N Broad St, Philadelphia, PA
  • Academic Office & Contact Information

    Academic Office:

    410 W 10th Ave
    Columbus, Ohio 43210-1228

  • Publications

    August 19, 2024

    Long-term disease-specific quality of life after laparoscopic Nissen fundoplication in patients with borderline GERD.

    Wang TN, Jalilvand AD, Sharma S, An BW, Perry KA, Sweigert PJ

    Surg Endosc

    June 27, 2024

    Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils.

    Shantaram D, Hoyd R, Blaszczak AM, Antwi L, Jalilvand A, Wright VP, Liu J, Smith AJ, Bradley D, Lafuse W, Liu Y, Williams NF, Snyder O, Wheeler C, Needleman B, Brethauer S, Noria S, Renton D, Perry KA, Nagareddy P, Wozniak D, Mahajan S, Rana PSJB, Pietrzak M, Schlesinger LS, Spakowicz DJ, Hsueh WA

    Nat Commun

    April 1, 2023

    Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

    Ajani JA, D'Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, Gibson M, Grierson P, Hofstetter WL, Ilson DH, Jalal S, Keswani RN, Kim S, Kleinberg LR, Klempner S, Lacy J, Licciardi F, Ly QP, Matkowskyj KA, McNamara M, Miller A, Mukherjee S, Mulcahy MF, Outlaw D, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian NR, Pluchino LA

    J Natl Compr Canc Netw

    April 8, 2022

    Adherence to Surveillance Endoscopies Posteradication of Barrett's Esophagus With High-grade Dysplasia or Carcinoma In Situ.

    Um PS, Chan MQ, Hinton A, Haisley K, Perry KA, Balasubramanian G

    J Clin Gastroenterol

    February 1, 2022

    Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

    Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA

    J Natl Compr Canc Netw

    April 21, 2020

    Perineural invasion predicts for locoregional failure in patients with oesophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy.

    Patel AK, Pan X, Vila DM, Frankel WL, Chen W, Perry KA, Merritt RE, D'Souza DM, Wuthrick EJ, Williams TM

    J Clin Pathol

  • Consulting and Related Relationships

    At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Perry has reported no relationships with companies or entities.